ZA936968B - Transcutaneous in vivo activation of photosensitive agents in blood - Google Patents
Transcutaneous in vivo activation of photosensitive agents in bloodInfo
- Publication number
- ZA936968B ZA936968B ZA936968A ZA936968A ZA936968B ZA 936968 B ZA936968 B ZA 936968B ZA 936968 A ZA936968 A ZA 936968A ZA 936968 A ZA936968 A ZA 936968A ZA 936968 B ZA936968 B ZA 936968B
- Authority
- ZA
- South Africa
- Prior art keywords
- target cells
- cells
- transcutaneous
- blood
- vivo activation
- Prior art date
Links
- 230000004913 activation Effects 0.000 title 1
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 238000001727 in vivo Methods 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 2
- 244000045947 parasite Species 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000003504 photosensitizing agent Substances 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94811392A | 1992-09-21 | 1992-09-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA936968B true ZA936968B (en) | 1994-04-12 |
Family
ID=25487290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA936968A ZA936968B (en) | 1992-09-21 | 1993-09-21 | Transcutaneous in vivo activation of photosensitive agents in blood |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US5484803A (xx) |
| EP (1) | EP0660712B1 (xx) |
| JP (2) | JP3598306B2 (xx) |
| AT (1) | ATE201596T1 (xx) |
| AU (1) | AU681088B2 (xx) |
| CA (1) | CA2144327C (xx) |
| DE (1) | DE69330277T2 (xx) |
| DK (1) | DK0660712T3 (xx) |
| ES (1) | ES2160600T3 (xx) |
| FI (1) | FI951295A (xx) |
| GR (1) | GR3036479T3 (xx) |
| HU (1) | HU220251B (xx) |
| IL (1) | IL107035A (xx) |
| NO (1) | NO951066L (xx) |
| NZ (1) | NZ255302A (xx) |
| PL (1) | PL308116A1 (xx) |
| PT (1) | PT660712E (xx) |
| SK (1) | SK35295A3 (xx) |
| TW (1) | TW241204B (xx) |
| WO (1) | WO1994006424A1 (xx) |
| ZA (1) | ZA936968B (xx) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6710066B2 (en) | 1989-07-28 | 2004-03-23 | Queen's University At Kingston | Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins |
| US5955490A (en) * | 1989-07-28 | 1999-09-21 | Queen's University At Kingston | Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins |
| US20020058008A1 (en) * | 1989-07-28 | 2002-05-16 | Kennedy James C. | Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins |
| US5587490A (en) * | 1990-04-16 | 1996-12-24 | Credit Managers Association Of California | Method of inactivation of viral and bacterial blood contaminants |
| US5798238A (en) * | 1990-04-16 | 1998-08-25 | Baxter International Inc. | Method of inactivation of viral and bacterial blood contaminants with quinolines as photosensitizer |
| US20040110819A1 (en) * | 1991-10-28 | 2004-06-10 | Queen's University At Kingston | Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins |
| PT947222E (pt) * | 1992-11-20 | 2006-09-29 | Univ British Columbia | Metodo de activacao de agentes fotossensiveis |
| WO1996039188A1 (en) * | 1995-06-05 | 1996-12-12 | Queen's University At Kingston | Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins |
| US6008211A (en) * | 1995-07-27 | 1999-12-28 | Pdt Pharmaceuticals, Inc. | Photoactivatable compounds comprising benzochlorin and furocoumarin |
| ATE235814T1 (de) * | 1995-11-06 | 2003-04-15 | New York Blood Ct Inc | Behandlung von roten blutzellen zur inaktivierung von virien durch verwendung von pathalocyanine und rotlicht |
| US5895786A (en) | 1996-05-08 | 1999-04-20 | New York Blood Center, Inc. | Method for treating viral infections |
| US6159733A (en) * | 1996-06-20 | 2000-12-12 | New York Blood Center, Inc. | Method for photoinactivating malignant cells |
| US5922278A (en) † | 1996-11-19 | 1999-07-13 | Baxter International Inc. | Method and apparatus for inactivating contaminants in biological fluid |
| US5742380A (en) * | 1996-12-31 | 1998-04-21 | Ronn Avigdor M | Plasma assay spectrometer |
| US6010890A (en) * | 1997-04-29 | 2000-01-04 | New York Blood Center, Inc. | Method for viral inactivation and compositions for use in same |
| US6103706A (en) * | 1997-04-29 | 2000-08-15 | New York Blood Center, Inc. | Methods for treating viral infections |
| US5856566A (en) * | 1997-09-02 | 1999-01-05 | Dusa Pharmaceuticals, Inc. | Sterilized 5-aminolevulinic acid |
| US6159178A (en) | 1998-01-23 | 2000-12-12 | Heartport, Inc. | Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested |
| US6096066A (en) * | 1998-09-11 | 2000-08-01 | Light Sciences Limited Partnership | Conformal patch for administering light therapy to subcutaneous tumors |
| US6183773B1 (en) | 1999-01-04 | 2001-02-06 | The General Hospital Corporation | Targeting of sebaceous follicles as a treatment of sebaceous gland disorders |
| US6602274B1 (en) * | 1999-01-15 | 2003-08-05 | Light Sciences Corporation | Targeted transcutaneous cancer therapy |
| JP2002534218A (ja) * | 1999-01-15 | 2002-10-15 | ライト サイエンシーズ コーポレイション | 非侵襲性の脈管療法 |
| CA2358662A1 (en) * | 1999-01-15 | 2000-07-20 | James Chen | Therapeutic compositions for metabolic bone disorders or bone metastases |
| US6454789B1 (en) * | 1999-01-15 | 2002-09-24 | Light Science Corporation | Patient portable device for photodynamic therapy |
| US6376483B1 (en) | 1999-05-27 | 2002-04-23 | Miravant Pharmaceuticals, Inc. | Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production |
| US20030114434A1 (en) * | 1999-08-31 | 2003-06-19 | James Chen | Extended duration light activated cancer therapy |
| DE19960705A1 (de) * | 1999-12-16 | 2001-06-21 | Laser & Med Tech Gmbh | Verfahren und Vorrichtung zur Herstellung eines autologen Immunisierungsimpfstoffes gegen Krebserkrankungen (Tumorvakzine) |
| US7897140B2 (en) | 1999-12-23 | 2011-03-01 | Health Research, Inc. | Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents |
| US20020049247A1 (en) * | 2000-01-12 | 2002-04-25 | Chen James C. | Novel treatment for eye disease |
| KR100365151B1 (ko) * | 2000-05-08 | 2003-02-11 | 김형락 | 어류 병원성 세균과 바이러스의 감염 예방 및 치료를 위한δ-아미노레불린산의 신규한 용도 |
| DE10034673C1 (de) | 2000-07-17 | 2002-04-25 | Medac Klinische Spezialpraep | Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung |
| EP2248536A3 (en) | 2000-12-14 | 2010-12-08 | The General Hospital Corporation doing business as Massachusetts General Hospital | Topical Aminolevulinic acid-photodynamic therapy for acne vulgaris |
| WO2002013788A1 (en) | 2000-08-16 | 2002-02-21 | The General Hospital Corporation D/B/A Massachusetts General Hospital | Topical aminolevulinic acid-photodynamic therapy for acne vulgaris |
| US7498029B2 (en) * | 2001-05-01 | 2009-03-03 | The General Hospital Corporation | Photoimmunotherapies for cancer using combination therapies |
| DE60219627T2 (de) * | 2001-06-04 | 2008-02-07 | The General Hospital Corp., Boston | Nachweis und therapie von empfindlichem plaque mit photodynamischen verbindungen |
| DE10162712A1 (de) * | 2001-12-19 | 2003-07-17 | Blutspendienst Der Landesverba | Verfahren zur Inaktivierung von Bakterien und Leukozyten in Blut oder Blutprodukten |
| JP2005527493A (ja) * | 2002-01-23 | 2005-09-15 | ライト サイエンシーズ コーポレイション | 光線力学療法のためのシステムおよび方法 |
| AU2003248747A1 (en) | 2002-06-27 | 2004-01-19 | Health Research, Inc. | Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
| EP2036908A3 (en) | 2002-07-02 | 2009-05-13 | Health Research, INC. | Efficient synthesis of pyropheophorbide a derivates |
| US7659301B2 (en) * | 2003-04-15 | 2010-02-09 | The General Hospital Corporation | Methods and devices for epithelial protection during photodynamic therapy |
| US7220778B2 (en) * | 2003-04-15 | 2007-05-22 | The General Hospital Corporation | Methods and devices for epithelial protection during photodynamic therapy |
| US20070020272A1 (en) * | 2003-04-30 | 2007-01-25 | Tayyaba Hasan | Indirectly linked photosensitizer immunoconjugates, processes for the production thereof and methods of use thereof |
| AU2004243004A1 (en) * | 2003-05-29 | 2004-12-09 | Mitos Pharmaceuticals, Inc. | Methods of using nitroxides in conjunction with photosensitizers and sonosensitizers |
| FR2857264A1 (fr) * | 2003-07-09 | 2005-01-14 | Maco Pharma Sa | Procede d'inactivation photodynamique des pathogenes au moyen d'ala |
| GB0424833D0 (en) | 2004-11-10 | 2004-12-15 | Photocure Asa | Method |
| US8585707B2 (en) | 2006-06-07 | 2013-11-19 | Gary S. Rogers | Continuous low irradiance photodynamic therapy method |
| US20080164224A1 (en) * | 2007-01-04 | 2008-07-10 | Whirlpool Corporation | System for connecting mechnically dissimilar consumer electronic devices to an adaptor or a host |
| CA2724949A1 (en) | 2007-06-27 | 2008-12-31 | The General Hospital Corporation | Method and apparatus for optical inhibition of photodynamic therapy |
| US20090062724A1 (en) * | 2007-08-31 | 2009-03-05 | Rixen Chen | System and apparatus for sonodynamic therapy |
| US8835104B2 (en) | 2007-12-20 | 2014-09-16 | Fenwal, Inc. | Medium and methods for the storage of platelets |
| EP2694131B1 (en) | 2011-04-07 | 2019-08-28 | Fenwal, Inc. | Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4649151A (en) * | 1982-09-27 | 1987-03-10 | Health Research, Inc. | Drugs comprising porphyrins |
| US5095030A (en) * | 1987-01-20 | 1992-03-10 | University Of British Columbia | Wavelength-specific cytotoxic agents |
| US4961920A (en) * | 1988-12-08 | 1990-10-09 | Luminis Pty, Ltd. | Phototherapeutic monovinyl and divinyl ether-linked dimers |
| US4960408A (en) * | 1989-01-10 | 1990-10-02 | Klainer Albert S | Treatment methods and vaccines for stimulating an immunological response against retroviruses |
-
1993
- 1993-09-20 JP JP50762994A patent/JP3598306B2/ja not_active Expired - Fee Related
- 1993-09-20 PL PL93308116A patent/PL308116A1/xx unknown
- 1993-09-20 DE DE69330277T patent/DE69330277T2/de not_active Expired - Fee Related
- 1993-09-20 NZ NZ255302A patent/NZ255302A/en unknown
- 1993-09-20 IL IL10703593A patent/IL107035A/en not_active IP Right Cessation
- 1993-09-20 ES ES93918860T patent/ES2160600T3/es not_active Expired - Lifetime
- 1993-09-20 AT AT93918860T patent/ATE201596T1/de not_active IP Right Cessation
- 1993-09-20 SK SK352-95A patent/SK35295A3/sk unknown
- 1993-09-20 EP EP93918860A patent/EP0660712B1/en not_active Expired - Lifetime
- 1993-09-20 CA CA002144327A patent/CA2144327C/en not_active Expired - Fee Related
- 1993-09-20 PT PT93918860T patent/PT660712E/pt unknown
- 1993-09-20 WO PCT/CA1993/000382 patent/WO1994006424A1/en active IP Right Grant
- 1993-09-20 DK DK93918860T patent/DK0660712T3/da active
- 1993-09-20 HU HU9500814A patent/HU220251B/hu not_active IP Right Cessation
- 1993-09-20 AU AU49405/93A patent/AU681088B2/en not_active Ceased
- 1993-09-21 ZA ZA936968A patent/ZA936968B/xx unknown
- 1993-10-05 TW TW082108212A patent/TW241204B/zh active
-
1995
- 1995-02-02 US US08/384,440 patent/US5484803A/en not_active Expired - Lifetime
- 1995-03-20 FI FI951295A patent/FI951295A/fi unknown
- 1995-03-20 NO NO951066A patent/NO951066L/no not_active Application Discontinuation
- 1995-11-08 US US08/555,235 patent/US5736563A/en not_active Expired - Fee Related
-
2001
- 2001-04-04 JP JP2001105544A patent/JP2001316288A/ja active Pending
- 2001-08-30 GR GR20010401338T patent/GR3036479T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU681088B2 (en) | 1997-08-21 |
| SK35295A3 (en) | 1996-05-08 |
| ATE201596T1 (de) | 2001-06-15 |
| JP2001316288A (ja) | 2001-11-13 |
| IL107035A (en) | 1998-12-27 |
| FI951295A0 (fi) | 1995-03-20 |
| US5484803A (en) | 1996-01-16 |
| NO951066D0 (no) | 1995-03-20 |
| DE69330277T2 (de) | 2002-04-18 |
| CA2144327A1 (en) | 1994-03-31 |
| FI951295A (fi) | 1995-05-17 |
| GR3036479T3 (en) | 2001-11-30 |
| ES2160600T3 (es) | 2001-11-16 |
| HUT70966A (en) | 1995-11-28 |
| NZ255302A (en) | 2001-04-27 |
| US5736563A (en) | 1998-04-07 |
| PL308116A1 (en) | 1995-07-24 |
| DE69330277D1 (de) | 2001-07-05 |
| JPH08501301A (ja) | 1996-02-13 |
| PT660712E (pt) | 2001-11-30 |
| AU4940593A (en) | 1994-04-12 |
| HU220251B (hu) | 2001-11-28 |
| EP0660712A1 (en) | 1995-07-05 |
| NO951066L (no) | 1995-05-19 |
| IL107035A0 (en) | 1993-12-28 |
| CA2144327C (en) | 2002-08-06 |
| WO1994006424A1 (en) | 1994-03-31 |
| JP3598306B2 (ja) | 2004-12-08 |
| TW241204B (xx) | 1995-02-21 |
| EP0660712B1 (en) | 2001-05-30 |
| DK0660712T3 (da) | 2001-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3036479T3 (en) | Transcutaneous in vivo activation of photosensitive agents in blood. | |
| AU1934699A (en) | Diode laser irradiation and electrotherapy system for biological tissue stimulation | |
| MY121548A (en) | Compounds and methods for the treatment of cancer | |
| CA2109084A1 (en) | Biofilm reduction method | |
| EP0361936A3 (en) | Lasing compositions and methods for using the same | |
| EP1114653A3 (en) | An implantable cardioversion device with a self-adjusting threshold for therapy selection | |
| FR2772622B1 (fr) | Dispositif medical implantable actif, notamment stimulateur cardiaque, defibrillateur et/ou cardioverteur, de type multisite configurable | |
| WO1999012951A8 (en) | Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases | |
| DE69623390D1 (de) | Aktive implantierbare medizinische Vorrichtung, insbesondere Herzschrittmacher oder Defibrillator | |
| PT768886E (pt) | Efeitos de revestimento endotelial e tratamento de desordens vasospasticas | |
| FR2774916B1 (fr) | Dispositif medical implantable actif, notamment stimulateur cardiaque, defibrillateur et/ou cardioverteur, de type multisite | |
| EP0950416A4 (en) | Preventive and / or therapeutic agent against cachexia | |
| UA37251C2 (uk) | Лікарський засіб для лікування або профілактики вірусної інфекції гепатиту в і спосіб лікування вірусної інфекції гепатиту в | |
| AU8168294A (en) | Solid insecticidal formulation | |
| EP0539516A4 (xx) | ||
| DE69937797D1 (de) | Alpha-emittierende konstrukte sowie deren verwendung | |
| RU96118110A (ru) | Предупреждение разрушения эритроцитов, стерилизованных фталоцианином и светом в присутствии витамина e и его производных | |
| RU95103472A (ru) | Способ лечения заразных форм сифилиса | |
| IT8920322A0 (it) | Procedimento di lotta biologica contro l'insetto distruttore di colture plutella xylostella utilizzante una poliedrosi nucleare e almeno un piretrinoide di sintesi. | |
| GR1002955B (el) | Προιοντα που προερχονται απο το φυτο κυπαρισσος και ολα τα συγγενη κωνοφορα, για χρηση στην προληψη και θεραπεια καθε τυπου υπερχοληστεριναιμιας και διαταραχης λιπιδιων, σε ανθρωπους και ζωα | |
| UA7163A (uk) | Спосіб відновлення ушкоджених тканин людини чи тварини |